Event Overview
This symposium aims to facilitate mutual understanding between Japan and UK public health experts in infectious diseases and SCARDA vaccine researchers and to discuss vaccine strategy for building a resilient global society capable of addressing future infectious disease outbreaks and other health challenges.
This event is a collaboration between Nagasaki University (School of Tropical Medicine and Global Health, DEJIMA Infectious Disease Research Alliance) and London School of Hygiene and Tropical Medicine (LSHTM).
Event Schedule and Registration
Symposium ‒ Vaccinology: Science and Public Health
*All the sessions are held in English.
23 September 2024
Open Sessions・Free
8:30 – 9:00 Registration 9:00 – 9:15 Welcome remarks 9:15 – 10:45 Session 1 – Public health: Value of vaccines against outbreak pathogens 11:15 – 12:45 Session 2 – Science: Vaccine development for pandemic preparedness 13:45 – 15:15 Session 3 – Science and Public Health: Partnership between vaccine development scientists and public health researchers 15:45 – 17:25 Session 4 – Young Researchers’ Oral presentations 17:30 – 19:30 Poster presentation & Networking reception
Symposium Program (to be updated)
Speakers
Opening remarks
AMED
(Director General, SCARDA)
Michinari Hamaguchi
Director,
Kouichi Morita
Session 1 – Public health: Value of vaccines against outbreak pathogens
Chair
Nagasaki Unviersity
Koya Ariyoshi
LSHTM and Nagasaki University
Laura Skrip
Cambridge University / Imperial College London
Caroline Trotter
Nagasaki Unviersity
Hiroyuki Moriuchi
Osaka University
Yoshihiro Takashima
Session 2 – Science: Vaccine development for pandemic preparedness
Chair
Nagasaki University
Satoshi Kaneko
Nagasaki Unviersity
Yoshimasa Tanaka
Nagasaki University
Sebastian Kapell
Nagasaki University
Shinjiro Hamano
Session 3 – Science and Public Health: Partnership between vaccine development scientists and public health researchers
LSHTM & Nagasaki University
Aurélia Vessière
International Vaccine Institute (IVI)
Sushant Sahastrabuddhe
LSHTM & Nagasaki University
John Edmunds
National Institute of Infectious Diseases
Motoi Suzuki
シンポジウム会場
Ryojun Auditorium
1-12-4 Sakamoto, Nagasaki City, Nagasaki Prefecture, JAPAN 852-8523
Short Course ‒ Vaccinology: Science and Public Health
Following the Symposium, a short course on Vaccinology: Science and Public Health will be held from 24th (Tue) to 27th (Fri) September 2024.
It is a didactic course to learn vaccinology from the viewpoint of both vaccine development and public health. All course participants are expected to join the symposium on 23rd (Mon) September 2024.
To participate in the course, an independent application and payment of the tuition fee are needed. Further details are available in the following link.
Short Course ‒ Vaccinology: Science and Public Health
Registration required
Schedule 24th Tue to 27th Fri September, 2024 Venue Global Health General Research Building, Sakamoto campus, Nagasaki University Tuition fee 100,000 JPY Course language English Course contents Please visit TMGH website
Vaccinology Course: Science and Public Health
Greetings
Greetings from the Director of the WISE Program
No matter how exceptional research outcomes may be, they alone do not lead to the promotion of health for people living on this planet. To realize a society where everyone can live healthier lives, achieving Health Equity as a goal, substantial collaboration across borders and disciplines, among individuals and organizations, is essential as a driving force in promoting global health.
Vaccines are among the most powerful tools we have for achieving Health Equity. Last year, we began collaborating with the Vaccine Research and Development Center in the DEJIMA Infectious Disease Research Alliance at Nagasaki University. This initiative brought together world-leading figures in infectious disease public health and Japanese vaccine development researchers, including Dr. Michinari Hamaguchi, Director of the Strategic Center of Biomedical Advanced Vaccine Research and Development for Preparedness and Response (SCARDA) at the Japan Agency for Medical Research and Development (AMED). Together, they engaged in highly productive discussions on building a resilient global society to tackle future emerging infectious diseases, particularly from the perspective of vaccine development. Highlights from the panel discussions held in February 2024 are available for on-demand viewing on our website, and I encourage you to watch them.
Based on this experience, we recognize the importance of expanding dialogue between infectious disease public health experts, who are the end-users of vaccines, and vaccine researchers. Therefore, we have planned an expanded version of this event. We look forward to the participation of not only public health practitioners but also vaccine researchers, infectious disease researchers, and clinicians working in the field with infectious disease patients.
We hope that this symposium will generate at least one new insight into what we should do now to maximize the power of vaccines, our most potent weapon, in achieving the goals of global health, which aim to value life and promote the sustainable development of humanity, and to protect humanity from the endless threat of infectious diseases.
Sincerely,
Director, Leading Graduate Program
Director, Leading Graduate Program
Kiyoshi Kita
Kiyoshi Kita
Greetings from the Director of the DEJIMA Infectious Disease Research Alliance
Director, Vaccine Research and Development Center
Director, Vaccine Research and Development Center
Kouichi Morita
Kouichi Morita
The Nagasaki University Vaccine Research and Development Center (VRDC) was established as one of the synergy centers of the AMED “Japan Initiative for World-leading Vaccine Research and Development Center” in the 2022 fiscal year.
Nagasaki University’s vaccine development research, in collaboration with companies such as Shionogi & Co., Ltd., NEC OncoImmunity AS, and KM Biologics Co., Ltd., promotes the development of vaccines targeting highly pathogenic and tropical pathogens. These developments plan to utilize new technologies such as lipid nanoparticles (LNP) and artificial intelligence (AI). Additionally, we aim to strengthen our collaboration with the London School of Hygiene & Tropical Medicine (LSHTM), a world leader in public health for infectious disease control, to gather information on infectious diseases from around the world and build a system capable of responding swiftly in emergencies.
The ultimate goal of the SCARDA project is to supply effective vaccines within 100 days during future global infectious disease outbreaks, thereby protecting the health and economy of the nation from infectious diseases. As vaccine development researchers bearing this mission, it is meaningful to engage in dialogue with public health experts who predict the speed and extent to which infectious diseases can become a threat to society and propose the effectiveness of various countermeasures. With this in mind, we held a symposium in Tokyo in February 2024. This time, we are presenting an expanded version of that event.
Engaging in discussions with public health experts who are in a position to propose the most effective ways to use vaccines to protect people’s health maximally is incredibly insightful for us researchers in guiding the future direction of our research. We look forward to the participation of many SCARDA researchers and related parties.
Sincerely,
Background of the Symposium
Nagasaki University, through its strategic partnership with the London School of Hygiene & Tropical Medicine (LSHTM), has been promoting faculty exchange, sharing and joint development of educational materials and programs, and multinational collaborative research in the field of global health. This partnership has resulted in various external funding such as the special university grant for reforming postgraduate education programme, the World-leading Innovative & Smart Education (WISE) Program, and research grants from the Bill & Melinda Gates Foundation.
Some significant milestones include the establishment of the School of Tropical Medicine and Global Health (TMGH) in 2015, the Satellite campus at the National Center for Global Health and Medicine (NCGM) in 2017, the Joint PhD Program in 2018, and the launch of the Diploma in Tropical Medicine and Hygiene (DTMH) course in 2020.
This is the 6th global health joint symposium. Previous WISE funded global health joint symposium have seen participation from researchers at Nagasaki University’s partner institutions, including the NCGM, the National Institute of Infectious Diseases (NIID), and researchers from the PREST young researchers (Director: Professor Hitoshi Oshitani, Tohoku University). These events have provided opportunities for domestic and international researchers in global health to expand their networks across various fields. Furthermore, the DEJIMA Infectious Disease Alliance has joined as a collaborator since the 5th global health joint symposium.
Past symposia
The 5th Nagasaki University WISE Global Health Symposium collaborating with SCARDA NU programme
Toward a global society resilient to emerging infectious diseases and other health issueshttps://iscgh2024.jp/
The 4th WISE programme Japan-UK Global Health Symposium
Online Japan-UK Symposium 2022
Online Japan-UK Symposium 2021
The 2nd Nagasaki University Global Health Forum
Nagasaki University WISE Programme – Kickoff Symposium
Privacy policy
Nagasaki University privacy policy https://www.nagasaki-u.ac.jp/ja/privacy/
